Titan Pharmaceuticals Inc. is a step closer to filing a new drug application (NDA) for its Probuphine as a weapon to fight opioid dependence. Topline results reported Monday showed the subcutaneous ...
The company also reported that its Kosciusko-1 well has been been treated with an anti-corrosion coating. Titan estimates that the well will be in production by Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback